LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

ClinicalTrials.gov ID: NCT03244020

Public ClinicalTrials.gov record NCT03244020. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Low Molecular Weight Heparin Versus Aspirin for Venous Thromboembolism Prophylaxis in Orthopaedic Oncology

Study identification

NCT ID: NCT03244020
Recruitment status: Enrolling by invitation
Study type: Interventional
Phase: Phase 4
Lead sponsor: Massachusetts General Hospital; Other
Enrollment: 2,868 participants

Conditions and interventions

Conditions

Interventions

Aspirin 325mg Drug
Enoxaparin 40Mg/0.4mL Prefilled Syringe Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 15, 2018
Primary completion: Dec 30, 2027
Completion: Jun 30, 2028
Last update posted: Oct 2, 2025

2018 – 2028

United States locations

U.S. sites: 10
U.S. states: 8
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of California Los Angeles Health	Los Angeles	California	90404	—
Moffitt Cancer Center	Tampa	Florida	33612	—
Louisiana State University Health	New Orleans	Louisiana	70112	—
Johns Hopkins University	Baltimore	Maryland	21287	—
Santiago Lozano-Calderon	Boston	Massachusetts	02114	—
Brigham and Women's Hospital	Boston	Massachusetts	02115	—
Beth Israel Deaconess Medical Center	Boston	Massachusetts	02215	—
University of Missouri-Columbia Cancer Care	Columbia	Missouri	65201	—
Cooper University Health Care	Camden	New Jersey	08103	—
Cleveland Clinic	Cleveland	Ohio	44195	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03244020, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 2, 2025 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03244020 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →